SubHero Banner
Text

Renflexis (infliximab-abda) – New biosimilar approval

April 21, 2017 – The FDA approved Renflexis (infliximab-abda), Merck and Samsung Bioepsis’ biosimilar to Janssen Biotech’s Remicade® (infliximab).

Download PDF